hasMedianSurvival

24 triples
GPTKB property

Random triples
Subject Object
gptkb:Anaplastic_thyroid_cancer <6 months
gptkb:oat_cell_carcinoma 16-24 months (limited stage)
gptkb:small_cell_lung_carcinoma 2-4 months untreated
gptkb:oat_cell_carcinoma 8-13 months (extensive stage)
gptkb:Small_Cell_Lung_Cancer 8-13 months (Extensive Stage)
gptkb:small_cell_lung_carcinoma 6-12 months with treatment
gptkb:anaplastic_thyroid_carcinoma less than 6 months
gptkb:angioimmunoblastic_T-cell_lymphoma 2-3 years
gptkb:Large_cell_lung_cancer 8-12 months (advanced stage)
gptkb:diffuse_astrocytoma 5-8 years
gptkb:unresectable_malignant_pleural_mesothelioma less than 1 year
gptkb:Combined_Small_Cell_Lung_Cancer Less than 1 year (advanced stage)
gptkb:glioblastoma 12-15 months
gptkb:North_American_ALS_patients 2 to 5 years after diagnosis
gptkb:anaplastic_thyroid_cancer <6 months
gptkb:Small_Cell_Lung_Cancer 16-24 months (Limited Stage)
gptkb:advanced_renal_cell_carcinoma less than 2 years (untreated)
gptkb:non-small_cell_lung_carcinoma less than 1 year (advanced stage)
gptkb:High-grade_glioma 2-3 years (anaplastic astrocytoma)
gptkb:glioblastoma_multiforme 12-15 months